Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.898
S.898: Fair Accountability and Innovative Research Drug Pricing Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 23, 2021
- Latest Major Action March 23, 2021
- See the four similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
5 (1 Democrat, 1 Independent Democrat, 3 Republicans)
Bill Version
- Introduced in Senate - March 23, 2021
Bill Summary
Fair Accountability and Innovative Research Drug Pricing Act of 2021 This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5)...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| March 23, 2021 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| March 23, 2021 |
Introduced in the Senate by Tammy Baldwin (D-Wis.) |